“…In this setting, core needle biopsy, magnetic resonance imaging (MRI), ultrasound findings, flourodeoxyglucose positron emission tomography (FDG-PET), different immunohistochemistry and genetic panels have been tried to better assess the malignancy risk [1]. For children, core needle biopsy may be achieved without an increased complication risk, although the accuracy of diagnosing malignancy seems to be equivalent to FNA [21]. Although immunohistochemical panels, PET, MRI and US seem promising to predict malignancy in adult thyroid nodules, none of the methods have been trialed specifically in a pediatric population, probably because of the rareness of the disease [22][23][24][25][26][27].…”